Thangavel, Chellappagounder <br/><br/>
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.  [electronic resource] 

 -  Endocrine-related cancer  Jun 2011 
 - 333-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1479-6821 
<br/><br/><label>Standard No.: </label>10.1530/ERC-10-0262  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--drug therapy<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cyclin D1--biosynthesis<br/>Female<br/>Gene Expression Profiling<br/>Humans<br/>Molecular Targeted Therapy<br/>Neoplasms, Hormone-Dependent--drug therapy<br/>Piperazines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyridines--pharmacology<br/>RNA, Messenger--biosynthesis<br/>Receptors, Estrogen--antagonists & inhibitors<br/>Retinoblastoma Protein--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction